INTEGRIS Nazih Zuhdi Transplant Institute
				
				Oklahoma City, Oklahoma 73112
We've found
        1 trials
        at this facility
      	
	Acute Antibody-Mediated Rejection (AMR) Clinical Trial
	
Updated: 12/31/1969
  
  
  A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney Transplant
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	